Drugs / MINTOX
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01982201 | Nov → Dec 2013 | — | Ardea Biosciences, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01622673 | Jun → Oct 2012 | HIV infectious disease | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MINTOX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01982201 ↗ |
| Known as | MINTOX Maximum Strength | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01622673 ↗ |